Why are GTS Chemical plc Hldg (+17%), Stanley Gibbons Group plc (-9%) and Redx Pharma plc (-10%) among today’s major movers?

Do major share price moves make these 3 stocks buys or sells? GTS Chemical plc Hldg (LON: GTS), Stanley Gibbons Group plc (LON: SGI) and Redx Pharma (LON: REDX)

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I’m taking a look at three companies that are among the major movers on the London stock market today.

A very important development

Shares in GTS Chemical (LSE: GTS) have soared by around 17% today after it announced that it has received a certificate of registration from the American Petroleum Institute for conformance with the API Specification Q1.

This specification should further establish GTS’s brands, which in turn could attract more distributors and differentiate the company from its competitors. And with its being received for the quality management on nine of GTS’s products — including the core business divisions of ammonium sulphite, ammonium bisulfite and lubricating oil — it could prove to be a very important development for the company.

Should you invest £1,000 in Redx Pharma Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Redx Pharma Plc made the list?

See the 6 stocks

Looking ahead, GTS is forecast to post a fall in earnings in the current year of 6%. While this could hurt investor sentiment in the short run, the speciality chemicals company is due to increase its bottom line by 13% next year. This puts it on a forward price to earnings (P/E) ratio of just 3.9, which indicates that its shares are cheap and could be due for an upward rerating over the medium to long term.

Disappointing performance 

Also among today’s major movers is Stanley Gibbons (LSE: SGI), with the antiques and stamp collector posting a fall in its share price of around 9%. Given the company’s woes during the course of the year, this is perhaps unsurprising since investor sentiment is now rather weak. In fact, Stanley Gibbons’ shares have fallen by 84% since the turn of the year and there could be more pain to come. That’s because the company is set to endure a challenging period, with profitability forecast to come under pressure in the next financial year.

While Stanley Gibbons has the potential to turn its disappointing performance around, its risk/reward ratio seems to be relatively unappealing. That’s especially the case since there are a number of other smaller companies that are on the cusp of improved financial performance and which offer good value for money at the present time.

In a stronger position

Meanwhile, shares in Redx Pharma (LSE: REDX) have been down by as much as 10% today despite the drug development company having released no significant news flow. Of course, Redx recently conducted a £10m placing and the proceeds are set to be used to progress the company’s drug pipeline and to also further develop Redx’s other assets in immune-oncology, infection and immunology. And with the net proceeds strengthening the company’s balance sheet, Redx seems to be in a stronger position after the placing.

Clearly, Redx’s share price performance since the start of the year has been very poor. Its valuation has declined by around 55% and while it has significant long term potential, it may prudent for risk averse investors to look for greater stability and consistency elsewhere in the health care space.

Should you buy Redx Pharma Plc now?

Don’t make any big decisions yet.

Because Mark Rogers — The Motley Fool UK’s Director of Investing — has revealed 5 Shares for the Future of Energy.

And he believes they could bring spectacular returns over the next decade.

Since the war in Ukraine, nations everywhere are scrambling for energy independence, he says. Meanwhile, they’re hellbent on achieving net zero emissions. No guarantees, but history shows...

When such enormous changes hit a big industry, informed investors can potentially get rich.

So, with his new report, Mark’s aiming to put more investors in this enviable position.

Click the button below to find out how you can get your hands on the full report now, and as a thank you for your interest, we’ll send you one of the five picks — absolutely free!

Grab your FREE Energy recommendation now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Close-up image depicting a woman in her 70s taking British bank notes from her colourful leather wallet.
Investing Articles

£10,000 invested in Tesco shares just a fortnight ago is already worth…

Tesco shares went through a sharp wobble a couple of weeks ago, but here's a look at what's happened to…

Read more »

Young female analyst working at her desk in the office
Investing Articles

9.6% yield! Here’s the dividend forecast for Glencore shares to 2027!

At nearly 10%, Glencore shares have one of the largest dividend yields on the FTSE 100. Here's why they could…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing Articles

£20,000 Stocks and Shares ISA: how long would it take to reach £1 million?

This writer considers how long it would take an investor to reach a seven-figure sum by maxing out their Stocks…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

UK bonds: a once-in-a-decade passive income opportunity?

Gilts are offering some very attractive yields at the moment. But Stephen Wright thinks passive income investors could still do…

Read more »

Frustrated young white male looking disconsolate while sat on his sofa holding a beer
Investing Articles

Down 99%, this stock has been crushed by AI and is now a penny share!

Chegg has gone from being a fast-growth tech stock to a penny share trading for less than $1 in the…

Read more »

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Could this rapidly growing coffee stock be the next Warren Buffett-style winner?

Discover why a fast-growing US coffee chain could be the next big US growth stock, with similarities to stocks picked…

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

2 high-yielding dividend stocks I continue to double down on

Andrew Mackie explores two FTSE 350 high-yielding dividend stocks he's been snapping up in the last few weeks for his…

Read more »

Stack of British pound coins falling on list of share prices
Investing Articles

Why did the AstraZeneca share price just fall, and what should we do?

The AstraZeneca share price just took a hit as President Trump announced a price war against the US pharmaceutical industry.

Read more »